Suppr超能文献

通过在弱有机酸浓水溶液中增溶并干燥制备的伊曲康唑固体分散体的表征

Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying.

作者信息

Parikh Tapan, Sandhu Harpreet K, Talele Tanaji T, Serajuddin Abu T M

机构信息

Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, 8000 Utopia Parkway, Queens, New York, 11439, USA.

Center of Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, 20903, USA.

出版信息

Pharm Res. 2016 Jun;33(6):1456-71. doi: 10.1007/s11095-016-1890-8. Epub 2016 Mar 7.

Abstract

PURPOSE

The purpose of this study was to develop an amorphous solid dispersion (SD) of an extremely water-insoluble and very weakly basic drug, itraconazole (ITZ), by interaction with weak organic acids and then drying that would enhance dissolution rate of drug and physical stability of formulation.

METHODS

Aqueous solubility of ITZ in concentrated solutions of weak organic acids, such as glutaric, tartaric, malic and citric acid, was determined. Solutions with high drug solubility were dried using vacuum oven and the resulting SDs having 2 to 20% drug load were characterized by differential scanning calorimetry (DSC), powder X-ray diffractometry (PXRD) and attenuated total reflectance-Fourier transform infrared (ATR-FTIR) spectroscopy. The dissolution of SDs was initially studied in 250 mL of 0.1 N HCl (pH 1.1), and any undissolved solids were collected and analyzed by PXRD. The pH of the dissolution medium was then changed from 1.1 to 5.5, particle size of precipitates were measured, and drug concentrations in solution were determined by filtration through membrane filters of varying pore sizes.

RESULTS

The aqueous solubility of ITZ was greatly enhanced in presence of weak acids. While the solubility of ITZ in water was ~4 ng/ mL, it increased to 25-40 mg per g of solution at 25°C and 200 mg per g of solution at 65°C at a high acid concentration leading to extremely high solubilization. PXRD of SDs indicated that ITZ was present in the amorphous form, wherein the acid formed a partially crystalline matrix. ATR-FTIR results showed possible weak interactions, such as hydrogen bonding, between drug and acid but there was no salt formation. SDs formed highly supersaturated solutions at pH 1.1 and had superior dissolution rate as compared to amorphous drug and physical mixtures of drug and acids. Following the change in pH from 1.1 to 5.5, ITZ precipitated as mostly nanoparticles, providing high surface area for relatively rapid redissolution.

CONCLUSIONS

A method of highly solubilizing an extremely water-insoluble drug, ITZ, in aqueous media and converting it into an amorphous form in a physically stable SD was successfully investigated. The dissolution rate and the extent of supersaturation of the drug in dissolution media improved greatly, and any precipitate formed at high pH had very small particle size.

摘要

目的

本研究的目的是通过与弱有机酸相互作用,然后干燥,开发一种极难溶于水且碱性非常弱的药物伊曲康唑(ITZ)的无定形固体分散体(SD),以提高药物的溶解速率和制剂的物理稳定性。

方法

测定了ITZ在戊二酸、酒石酸、苹果酸和柠檬酸等弱有机酸浓溶液中的水溶性。使用真空烘箱干燥具有高药物溶解度的溶液,并用差示扫描量热法(DSC)、粉末X射线衍射法(PXRD)和衰减全反射傅里叶变换红外光谱(ATR-FTIR)对所得载药量为2%至20%的SD进行表征。首先在250 mL 0.1 N HCl(pH 1.1)中研究SD的溶出度,收集任何未溶解的固体并用PXRD进行分析。然后将溶出介质的pH从1.1变为5.5,测量沉淀物的粒径,并通过不同孔径的膜过滤器过滤测定溶液中的药物浓度。

结果

在弱酸存在下,ITZ的水溶性大大提高。虽然ITZ在水中的溶解度约为4 ng/mL,但在高酸浓度下,在25°C时其溶解度增加到每克溶液25 - 40 mg,在65°C时增加到每克溶液200 mg,导致极高的增溶效果。SD的PXRD表明ITZ以无定形形式存在,其中酸形成了部分结晶基质。ATR-FTIR结果显示药物与酸之间可能存在弱相互作用,如氢键,但没有形成盐。SD在pH 1.1时形成高度过饱和溶液,与无定形药物以及药物与酸的物理混合物相比,具有优异的溶解速率。在pH从1.1变为5.5后,ITZ主要以纳米颗粒形式沉淀,为相对快速的再溶解提供了高表面积。

结论

成功研究了一种在水性介质中高度增溶极难溶于水的药物ITZ并将其转化为物理稳定的SD中的无定形形式的方法。药物在溶出介质中的溶解速率和过饱和度大大提高,并且在高pH下形成的任何沉淀物粒径都非常小。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验